Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Head and Neck Neoplasms × Sonazoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1 Breast 1

Conditions

Melanoma 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 4 Cisplatin 4 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Paclitaxel 2 Fluorouracil 2 Docetaxel 2 ponatinib 1 bempegaldesleukin 1 alovudine 1 Thioctic Acid 1 Sonazoid 1 Radiation 1 Pilocarpine 1 Gemcitabine 1 Fluconazole 1 Exercise 1 Carboplatin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

The Netherlands Cancer Institute

Phase 2/3 Recruiting

BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡